JP2020007356A5 - - Google Patents

Download PDF

Info

Publication number
JP2020007356A5
JP2020007356A5 JP2019168569A JP2019168569A JP2020007356A5 JP 2020007356 A5 JP2020007356 A5 JP 2020007356A5 JP 2019168569 A JP2019168569 A JP 2019168569A JP 2019168569 A JP2019168569 A JP 2019168569A JP 2020007356 A5 JP2020007356 A5 JP 2020007356A5
Authority
JP
Japan
Prior art keywords
eye drop
aqueous
cellulose
ophthalmic solution
buffer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019168569A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020007356A (ja
JP6886502B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2020007356A publication Critical patent/JP2020007356A/ja
Publication of JP2020007356A5 publication Critical patent/JP2020007356A5/ja
Priority to JP2021082578A priority Critical patent/JP7224390B2/ja
Application granted granted Critical
Publication of JP6886502B2 publication Critical patent/JP6886502B2/ja
Priority to JP2023016850A priority patent/JP2023058574A/ja
Priority to JP2025032538A priority patent/JP2025084921A/ja
Priority to JP2025153045A priority patent/JP2025176149A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019168569A 2016-05-25 2019-09-17 アトロピン含有水性組成物 Active JP6886502B2 (ja)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2021082578A JP7224390B2 (ja) 2016-05-25 2021-05-14 アトロピン含有水性組成物
JP2023016850A JP2023058574A (ja) 2016-05-25 2023-02-07 アトロピン含有水性組成物
JP2025032538A JP2025084921A (ja) 2016-05-25 2025-03-03 アトロピン含有水性組成物
JP2025153045A JP2025176149A (ja) 2016-05-25 2025-09-16 アトロピン含有水性組成物

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SG10201604200P 2016-05-25
SG10201604200P 2016-05-25

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2017102939A Division JP6590860B2 (ja) 2016-05-25 2017-05-24 アトロピン含有水性組成物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021082578A Division JP7224390B2 (ja) 2016-05-25 2021-05-14 アトロピン含有水性組成物

Publications (3)

Publication Number Publication Date
JP2020007356A JP2020007356A (ja) 2020-01-16
JP2020007356A5 true JP2020007356A5 (enExample) 2021-04-15
JP6886502B2 JP6886502B2 (ja) 2021-06-16

Family

ID=60411416

Family Applications (6)

Application Number Title Priority Date Filing Date
JP2017102939A Active JP6590860B2 (ja) 2016-05-25 2017-05-24 アトロピン含有水性組成物
JP2019168569A Active JP6886502B2 (ja) 2016-05-25 2019-09-17 アトロピン含有水性組成物
JP2021082578A Active JP7224390B2 (ja) 2016-05-25 2021-05-14 アトロピン含有水性組成物
JP2023016850A Withdrawn JP2023058574A (ja) 2016-05-25 2023-02-07 アトロピン含有水性組成物
JP2025032538A Pending JP2025084921A (ja) 2016-05-25 2025-03-03 アトロピン含有水性組成物
JP2025153045A Pending JP2025176149A (ja) 2016-05-25 2025-09-16 アトロピン含有水性組成物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2017102939A Active JP6590860B2 (ja) 2016-05-25 2017-05-24 アトロピン含有水性組成物

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2021082578A Active JP7224390B2 (ja) 2016-05-25 2021-05-14 アトロピン含有水性組成物
JP2023016850A Withdrawn JP2023058574A (ja) 2016-05-25 2023-02-07 アトロピン含有水性組成物
JP2025032538A Pending JP2025084921A (ja) 2016-05-25 2025-03-03 アトロピン含有水性組成物
JP2025153045A Pending JP2025176149A (ja) 2016-05-25 2025-09-16 アトロピン含有水性組成物

Country Status (15)

Country Link
US (2) US20210267885A1 (enExample)
EP (2) EP3463360B1 (enExample)
JP (6) JP6590860B2 (enExample)
KR (4) KR102804061B1 (enExample)
CN (3) CN117205209A (enExample)
AR (1) AR108591A1 (enExample)
CA (1) CA3023149C (enExample)
EA (1) EA201892703A1 (enExample)
ES (1) ES2929368T3 (enExample)
MY (1) MY189774A (enExample)
PH (1) PH12018502421A1 (enExample)
SG (1) SG11201809822SA (enExample)
TW (3) TWI849355B (enExample)
UA (1) UA126195C2 (enExample)
WO (1) WO2017204262A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016172712A2 (en) * 2015-04-23 2016-10-27 Sydnexis, Inc. Ophthalmic composition
US9421199B2 (en) 2014-06-24 2016-08-23 Sydnexis, Inc. Ophthalmic composition
EP3302426A4 (en) 2015-05-29 2018-12-05 Sydnexis, Inc. D2o stabilized pharmaceutical formulations
CN110545813A (zh) * 2017-02-21 2019-12-06 新加坡保健服务集团 包含阿托品的用于防止或延迟近视发作的组合物和方法
WO2018209051A1 (en) 2017-05-11 2018-11-15 Nevakar Inc. Atropine pharmaceutical compositions
CN109157503B (zh) * 2018-09-25 2019-08-16 沈阳兴齐眼药股份有限公司 防治nitm的药物组合物及其医药用途
CN110934816B (zh) * 2018-09-25 2022-04-08 沈阳兴齐眼科医院有限公司 一种提高低浓度阿托品眼用制剂稳定性的方法
PT3701938T (pt) 2019-03-01 2024-01-31 Medivis S R L Formulações oftálmicas à base de atropina
JP2022539639A (ja) 2020-08-04 2022-09-13 参天製薬株式会社 近視の治療、近視の予防および／または近視の進行抑制のための医薬
WO2022080397A1 (ja) * 2020-10-14 2022-04-21 参天製薬株式会社 安定な医薬組成物
MX2023005056A (es) 2020-11-02 2023-07-24 Trethera Corp Formas cristalinas de un inhibidor de cinasa de desoxicitidina y sus usos.
WO2022130337A1 (en) * 2020-12-17 2022-06-23 Sun Pharmaceutical Industries Limited An aqueous sterile solution of atropine for ophthalmic use
EP4088713A1 (en) 2021-05-10 2022-11-16 Warszawskie Zaklady Farmaceutyczne Polfa S.A. Ophthalmic pharmaceutical composition comprising atropine
EP4088714A1 (en) 2021-05-10 2022-11-16 Warszawskie Zaklady Farmaceutyczne Polfa S.A. Ophthalmic pharmaceutical composition comprising atropine
US20230120997A1 (en) * 2021-10-18 2023-04-20 Ocular Science, Inc. Compositions and methods for myopia control and orthokeratology lenses treatment
CN114129511A (zh) * 2021-12-07 2022-03-04 河南润弘制药股份有限公司 一种具有改进稳定性的硫酸阿托品注射液
US12527739B2 (en) * 2022-09-11 2026-01-20 Alcon Inc. Aqueous pharmaceutical compositions comprising benzyl atropine and uses thereof
JP7665073B1 (ja) 2024-04-05 2025-04-18 ロート製薬株式会社 容器に収容してなる眼科用組成物
JP7723851B1 (ja) * 2024-11-22 2025-08-14 参天製薬株式会社 アトロピン含有水性医薬組成物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2617508B2 (ja) * 1988-02-05 1997-06-04 エーザイ株式会社 安定なジフェンヒドラミン含有水溶液
JP3166002B2 (ja) * 1997-01-27 2001-05-14 日本車輌製造株式会社 自動車の洗浄装置
US20030096831A1 (en) 2000-01-18 2003-05-22 Stone Richard A. Ocular growth and nicotinic antagonists
KR20040018380A (ko) * 2001-05-25 2004-03-03 밸리 포지 파마슈티컬즈, 인크. 피렌제핀 안약 겔제
US20070254914A1 (en) * 2006-05-01 2007-11-01 Non-Profit Organization Chang Gung Memorial Hospital Low-concentration atropine solution for preventing myopia progression and preparing method thereof
JP2007308398A (ja) * 2006-05-17 2007-11-29 Chang Gung Memorial Hospital 目薬、及びその製造方法
AU2008254428A1 (en) * 2007-05-21 2008-11-27 Neuroptix Corporation Ophthalmic formulations of Amyloid-beta contrast agents and methods of use thereof
CN101327216A (zh) * 2007-06-22 2008-12-24 肖正连 一种硫酸阿托品眼用即型凝胶
WO2012161655A1 (en) * 2011-05-23 2012-11-29 Singapore Health Services Pte Ltd Composition and/or method for reducing and/or preventing myopia progression comprising atropine
US9421199B2 (en) * 2014-06-24 2016-08-23 Sydnexis, Inc. Ophthalmic composition
US20160009705A1 (en) 2014-06-24 2016-01-14 Sydnexis, Inc. Ophthalmic composition
JP2017102939A (ja) * 2016-12-26 2017-06-08 株式会社プロフィールド オーサリング装置、オーサリング方法、およびプログラム
WO2018209051A1 (en) * 2017-05-11 2018-11-15 Nevakar Inc. Atropine pharmaceutical compositions

Similar Documents

Publication Publication Date Title
JP2020007356A5 (enExample)
JP2018021007A5 (enExample)
JP7224390B2 (ja) アトロピン含有水性組成物
US7235247B2 (en) Pharmaceutical composition for application to mucosa
RU2010141542A (ru) Низковязкие высокофлокулированные суспензии триамцинолона ацетонида для интравитреальных инъекций
CA2760140C (en) Topical solution formulations containing a corticosteroid and a cyclodextrin
JP2011513492A5 (enExample)
CA2505742A1 (en) Pharmaceutical compositions comprising a basic drug, a water soluble acid and a surfactant
JP2013513612A5 (enExample)
JP6094388B2 (ja) ペメトレキセドを含む注射用組成物
JP2015007136A5 (enExample)
JP2013535472A5 (enExample)
JP2021191802A5 (enExample)
ES2791360T3 (es) Composiciones oftálmicas que comprenden iota-carragenina
KR20070005625A (ko) 나트륨 카르복시메틸셀룰로스 및히드록시프로필메틸셀룰로스를 포함하는 안과 용액
JP5276591B2 (ja) ピレノキシン含有二液性点眼剤
JP2021119164A5 (enExample)
CN110022856B (zh) 用于降低眼压的眼用组合物
EA201800091A1 (ru) Лекарственный препарат на основе 5-амино-2,3-дигидрофталазин-1,4-диона в виде быстрорастворимой пленки для трансбуккального введения
TH1801007190A (th) องค์ประกอบเอเควียสที่มีอะโทรปีนประกอบอยู่
JP2019532927A5 (enExample)
JP2008513529A5 (enExample)
RU2024110746A (ru) Пероральная суспензия тадалафила
NZ782902A (en) Oxymetazoline compositions and methods for treating ocular disorders
CN110799188A (zh) 基于托品酰胺的眼用制剂